0001209191-22-025477.txt : 20220425
0001209191-22-025477.hdr.sgml : 20220425
20220425100054
ACCESSION NUMBER: 0001209191-22-025477
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06c
FILED AS OF DATE: 20220425
DATE AS OF CHANGE: 20220425
EFFECTIVENESS DATE: 20220425
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytoDyn Inc.
CENTRAL INDEX KEY: 0001175680
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 753056237
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-442934
FILM NUMBER: 22847638
BUSINESS ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
BUSINESS PHONE: 360-980-8524
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
FORMER COMPANY:
FORMER CONFORMED NAME: CYTODYN INC
DATE OF NAME CHANGE: 20031114
FORMER COMPANY:
FORMER CONFORMED NAME: REXRAY CORP
DATE OF NAME CHANGE: 20020617
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001175680
CytoDyn Inc.
1111 Main Street
Suite 660
Vancouver
WA
WASHINGTON
98660
360-980-8524
DELAWARE
Rexray Corporation
CYTODYN INC
REXRAY CORP
Corporation
true
Scott
A.
Kelly
1111 Main Street
Suite 660
Vancouver
WA
WASHINGTON
98660
Executive Officer
Director
Karen
J.
Brunke
1111 Main Street
Suite 660
Vancouver
WA
WASHINGTON
98660
Director
Lishomwa
C.
Ndhlovu
1111 Main Street
Suite 660
Vancouver
WA
WASHINGTON
98660
Director
Jordan
G.
Naydenov
1111 Main Street
Suite 660
Vancouver
WA
WASHINGTON
98660
Director
Tanya
Durkee
Urbach
1111 Main Street
Suite 660
Vancouver
WA
WASHINGTON
98660
Director
Antonio
Migliarese
1111 Main Street
Suite 660
Vancouver
WA
WASHINGTON
98660
Executive Officer
Nitya
G.
Ray
1111 Main Street
Suite 660
Vancouver
WA
WASHINGTON
98660
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06c
true
0001209191-22-025264
2022-04-07
false
true
true
true
true
Common Stock; Warrants to Purchase Common Stock; Common Stock issued upon exercise of Warrants
false
25000
Paulson Investment Company
2670
None
None
40 Wall Street
39th Floor
New York
NY
NEW YORK
10005
All States
Indefinite
1890000
Indefinite
false
21
2600000
true
0
Based on estimate of gross proceeds.
Excludes warrants to purchase Common Stock.
600000
true
false
CytoDyn Inc.
/s/ Antonio Migliarese
Antonio Migliarese
CFO & Interim President
2022-04-25